NeoGenomics has exercised its option to buy Inivata, a precision cancer diagnostics company that was formed to exploit Cambridge and CRUK research seven years ago.

Solidia Technologies, Kelun Biotech and Doer Biologics all raised more than $70m while Sony added cash to a round valuing Discord at $7bn.

Oxford University Innovation has revealed it launched 37 new companies between April 2020 and March 2021, its best run yet.

Dexxon, SoftBank and Sumitomo Dainippon-backed medical company builder Roivant Sciences will get a public listing through the transaction.

Nikon contributed to a $270m round valuing the DNA sequencing eqiupment producer at $3.4bn as it prepares to pursue a public listing.

The Virgin-backed online pharmacy services provider was valued above $1bn in a round that boosted its overall funding to $570m.

The Taiho and UPMC-backed cancer biotherapeutics developer priced its shares in the middle of their range in its initial public offering.

CVS Health Ventures has been launched to formalise an investment strategy that has backed the likes of Unite Us and LumiraDx.

Driverless vehicle developer EasyMile closed a $66.4m round featuring Alstom and Continental while UCB and LivaNova-backed EEG technology developer Ceribell secured $53m.